+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Growth Opportunities in Nanomaterials and Nanomedicine

  • PDF Icon


  • 29 Pages
  • December 2021
  • Region: Global
  • Frost & Sullivan
  • ID: 5527560

This issue of the Nanotechnology Opportunity Engine covers growth opportunities in nanomaterials and nanomedicine. The TOE focuses on use of nanotechnology for medicine, such as a polymeric nanoparticle technology that offers therapeutic benefits in nanomedicines for cancer treatment, a nanoemulsion platform that enables intranasal vaccines for challenging respiratory diseases, and metal nanocrystals for the healthcare industry. The TOE also covers nanotechnology applications in batteries, such as, enhancing the efficiency of lithium-ion batteries, graphene organolyte batteries that offer a wide temperature range for all weather applications, and a green fabrication process for battery coatings. The TOE also profiles on-chip grade quantum dots printed on wafer scale to offer more fabrication opportunity, fabricating a sustainable alternative for electric vehicles, and reusable nanocatalysts for waste-to-x technology.

The Nanotechnology Opportunity Engine provides intelligence on technologies, products, processes, applications, and strategic insights on nanotechnology-related innovations and their impact across various industries. Technology focus areas include nanocatalysts, antimicrobials, nanocellulose, and nanoplatelets.

The Chemicals and Advanced Materials cluster tracks research and innovation trends and developments across specialty chemicals, plastics, polymers, chemicals, bio-chemicals, metals, coatings, thinfilms, surface treatments, composites, alloys, oil and gas, fuel additives, fibers, and several other related technologies and its impact and application across industries.

Table of Contents

Growth Opportunities in Nanomaterials and Nanomedicine

  • Technology Advances in Nanomaterials and Nanomedicine
    • Polymeric Micelle Technology to Offer High Specificity in Tumor Targeting for Cancer Treatment
    • Onconano Omni™ Platform Promises Innovative Immunotherapy Offering Enhanced Accumulation and Drug Retention
    • Onconano - Investor Dashboard
    • Polymeric Nanoparticle Technology to Offer Improved Therapeutic Benefits in Nanomedicines for Cancer Treatment
    • Cristal Therapeutics Cripec® Technology to Promise Broad Applicability With Different Therapeutic Modalities
    • Cristal Therapeutics - Investor Dashboard
    • Nanoemulsion Platform to Enable Development of Intranasal Vaccines for Challenging Respiratory Diseases
    • Bluewillow Nanovax® Technology to Effectively Reduce Early-Stage Transmission of Viruses
    • Bluewillow Biologics - Investor Dashboard
    • Graphene Organolyte Batteries to Offer a Wide Temperature Range for All Weather Applications
    • Non-Flammable Graphene Batteries to Offer Fast Charging, Slow Discharge Rate, and Higher Energy Storage Capacity
    • Nanotech Energy - Investor Dashboard
    • On-Chip Grade Quantum Dots Printed or Applied on a Wafer Scale Offer More Fabrication Opportunity
    • Non-Flammable Graphene Batteries to Offer Fast Charging, Slow Discharge Rate, and Higher Energy Storage Capacity
    • Qustomdot Bv - Investor Dashboard
    • Enhancing the Efficiency of Lithium-Ion Batteries
    • Metal Nanocrystals for the Healthcare Industry
    • Green Fabrication Process for Battery Coatings
    • Fabricating a Sustainable Alternative for Electric Vehicles
    • Reusable Nanocatalysts for ‘Waste-To-X’ Technology
  • Key Contacts
    • Key Contacts
    • Legal Disclaimer

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Onconano 
  • Cristal Therapeutics
  • Bluewillow Biologics
  • Nanotech Energy
  • Qustomdot Bv